Your browser doesn't support javascript.
loading
Correction to: GMMA Technology for the Development of Safe Vaccines: Meta-Analysis of Individual Patient Data to Assess the Safety Profile of Shigella sonnei 1790GAHB Vaccine in Healthy Adults, with Special Focus on Neutropenia.
De Ryck, Iris; Sarakinou, Eleanna; Nakakana, Usman; Cilio, Giulia Luna; Ndiaye, Augustin; Vella, Venanzio; Auerbach, Joachim; Granada, Juan-Paolo; Conti, Valentino; Podda, Audino.
Affiliation
  • De Ryck I; GSK, Siena, Italy. iris.x.de-ryck@gsk.com.
  • Sarakinou E; GSK Vaccines Institute for Global Health, Via Fiorentina 1, 53100, Siena, Italy.
  • Nakakana U; GSK Vaccines Institute for Global Health, Via Fiorentina 1, 53100, Siena, Italy.
  • Cilio GL; GSK, Siena, Italy.
  • Ndiaye A; Takeda Pharmaceutical International AG, Zurich, Switzerland.
  • Vella V; GSK, Siena, Italy.
  • Auerbach J; GSK Vaccines Institute for Global Health, Via Fiorentina 1, 53100, Siena, Italy.
  • Granada JP; Coalition for Epidemic Preparedness Innovations, London, UK.
  • Conti V; Ferring Pharmaceuticals, Copenhagen, Denmark.
  • Podda A; GSK Vaccines Institute for Global Health, Via Fiorentina 1, 53100, Siena, Italy.
Infect Dis Ther ; 11(3): 1313, 2022 Jun.
Article in En | MEDLINE | ID: mdl-35435576
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Systematic_reviews Language: En Journal: Infect Dis Ther Year: 2022 Type: Article Affiliation country: Italy
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Systematic_reviews Language: En Journal: Infect Dis Ther Year: 2022 Type: Article Affiliation country: Italy